B. Müller et al., “Severe cutaneous toxicity in a 67-year-old patient with metastatic urothelial carcinoma undergoing therapy with enfortumab vedotin and pembrolizumab”, EJCRIM, vol. 11, no. 12, Nov. 2024, doi: 10.12890/2024_005003.